KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Times Interest Earned: 2011-2025

Historic Times Interest Earned for Travere Therapeutics (TVTX) over the last 3 years, with Sep 2025 value amounting to $8.90.

  • Travere Therapeutics' Times Interest Earned rose 144.40% to $8.90 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.03, marking a year-over-year increase of 74.78%. This contributed to the annual value of -$28.91 for FY2024, which is 15.57% up from last year.
  • Latest data reveals that Travere Therapeutics reported Times Interest Earned of $8.90 as of Q3 2025, which was up 300.32% from -$4.44 recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Times Interest Earned peaked at $8.90 during Q3 2025, and registered a low of -$49.73 during Q1 2024.
  • Its 3-year average for Times Interest Earned is -$22.85, with a median of -$22.94 in 2024.
  • Data for Travere Therapeutics' Times Interest Earned shows a peak YoY surged of 144.40% (in 2025) over the last 5 years.
  • Over the past 3 years, Travere Therapeutics' Times Interest Earned (Quarterly) stood at -$33.40 in 2023, then skyrocketed by 35.06% to -$21.69 in 2024, then surged by 144.40% to $8.90 in 2025.
  • Its last three reported values are $8.90 in Q3 2025, -$4.44 for Q2 2025, and -$14.72 during Q1 2025.